tiprankstipranks
Trending News
More News >
TOT BIOPHARM International Co. Ltd. (HK:1875)
:1875
Hong Kong Market

TOT BIOPHARM International Co. Ltd. (1875) Financial Statements

Compare
0 Followers

TOT BIOPHARM International Co. Ltd. Financial Overview

TOT BIOPHARM International Co. Ltd.'s market cap is currently HK$1.48B. The company's EPS TTM is HK$0.004; its P/E ratio is 36.94; TOT BIOPHARM International Co. Ltd. is scheduled to report earnings on March 11, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 1.10B¥ 780.63M¥ 442.18M¥ 76.33M¥ 22.49M
Gross Profit¥ 782.43M¥ 573.99M¥ 370.62M¥ 27.47M¥ 15.53M
Operating Income¥ 41.25M¥ -33.06M¥ -39.08M¥ -259.70M¥ -288.67M
EBITDA¥ 84.96M¥ 10.45M¥ -5.41M¥ -224.51M¥ -254.71M
Net Income¥ 34.76M¥ -37.76M¥ -49.92M¥ -261.22M¥ -288.50M
Balance Sheet
Cash & Short-Term Investments¥ 381.26M¥ 358.36M¥ 458.05M¥ 152.81M¥ 225.53M
Total Assets¥ 1.51B¥ 1.43B¥ 1.26B¥ 710.26M¥ 641.18M
Total Debt¥ 395.47M¥ 345.65M¥ 289.53M¥ 208.56M¥ 7.41M
Net Debt¥ 14.21M¥ -5.95M¥ -128.24M¥ 55.76M¥ -218.13M
Total Liabilities¥ 779.12M¥ 739.41M¥ 546.59M¥ 375.17M¥ 58.83M
Stockholders' Equity¥ 729.65M¥ 686.69M¥ 713.88M¥ 335.09M¥ 582.36M
Cash Flow
Free Cash Flow¥ 0.00¥ -146.77M¥ -180.19M¥ -290.45M¥ -285.30M
Operating Cash Flow¥ 0.00¥ 56.43M¥ 59.93M¥ -175.14M¥ -263.12M
Investing Cash Flow¥ 0.00¥ -164.10M¥ -282.76M¥ -108.39M¥ 12.53M
Financing Cash Flow¥ 0.00¥ 38.23M¥ 481.24M¥ 212.08M¥ -61.71M
Currency in CNY

TOT BIOPHARM International Co. Ltd. Earnings and Revenue History

TOT BIOPHARM International Co. Ltd. Debt to Assets

TOT BIOPHARM International Co. Ltd. Cash Flow

TOT BIOPHARM International Co. Ltd. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis